SIR4_HUMAN - dbPTM
SIR4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SIR4_HUMAN
UniProt AC Q9Y6E7
Protein Name NAD-dependent protein lipoamidase sirtuin-4, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03161, ECO:0000303|PubMed:25525879}
Gene Name SIRT4 {ECO:0000255|HAMAP-Rule:MF_03161, ECO:0000312|HGNC:HGNC:14932}
Organism Homo sapiens (Human).
Sequence Length 314
Subcellular Localization Mitochondrion matrix .
Protein Description Acts as NAD-dependent protein lipoamidase, ADP-ribosyl transferase and deacetylase. Catalyzes more efficiently removal of lipoyl- and biotinyl- than acetyl-lysine modifications. Inhibits the pyruvate dehydrogenase complex (PDH) activity via the enzymatic hydrolysis of the lipoamide cofactor from the E2 component, DLAT, in a phosphorylation-independent manner. [PubMed: 25525879 Catalyzes the transfer of ADP-ribosyl groups onto target proteins, including mitochondrial GLUD1, inhibiting GLUD1 enzyme activity. Acts as a negative regulator of mitochondrial glutamine metabolism by mediating mono ADP-ribosylation of GLUD1: expressed in response to DNA damage and negatively regulates anaplerosis by inhibiting GLUD1, leading to block metabolism of glutamine into tricarboxylic acid cycle and promoting cell cycle arrest]
Protein Sequence MKMSFALTFRSAKGRWIANPSQPCSKASIGLFVPASPPLDPEKVKELQRFITLSKRLLVMTGAGISTESGIPDYRSEKVGLYARTDRRPIQHGDFVRSAPIRQRYWARNFVGWPQFSSHQPNPAHWALSTWEKLGKLYWLVTQNVDALHTKAGSRRLTELHGCMDRVLCLDCGEQTPRGVLQERFQVLNPTWSAEAHGLAPDGDVFLSEEQVRSFQVPTCVQCGGHLKPDVVFFGDTVNPDKVDFVHKRVKEADSLLVVGSSLQVYSGYRFILTAWEKKLPIAILNIGPTRSDDLACLKLNSRCGELLPLIDPC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
13AcetylationALTFRSAKGRWIANP
EEEEECCCCCEEECC
50.7012432727
26AcetylationNPSQPCSKASIGLFV
CCCCCCCCCEEEEEE
53.5212432737
43AcetylationSPPLDPEKVKELQRF
CCCCCHHHHHHHHHH
65.0912432745
61PhosphorylationSKRLLVMTGAGISTE
HHHHHHHCCCCCCCC
19.1923532336
69PhosphorylationGAGISTESGIPDYRS
CCCCCCCCCCCCHHH
41.9523532336
78UbiquitinationIPDYRSEKVGLYART
CCCHHHHCCEEEEEC
42.73-
255PhosphorylationKRVKEADSLLVVGSS
HHHHHCCEEEEECCE
30.5617924679
261PhosphorylationDSLLVVGSSLQVYSG
CEEEEECCEEEEECC
19.1017924679
262PhosphorylationSLLVVGSSLQVYSGY
EEEEECCEEEEECCC
19.5217924679
299UbiquitinationSDDLACLKLNSRCGE
CCHHHHHHCCCCCCC
45.5729967540

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SIR4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SIR4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SIR4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SIR3_HUMANSIRT3physical
17715127
IDE_HUMANIDEphysical
17715127
ADT2_HUMANSLC25A5physical
17715127
ADT3_HUMANSLC25A6physical
17715127
DHE3_MOUSEGlud1physical
16959573
CH60_HUMANHSPD1physical
26186194
SNX3_HUMANSNX3physical
26186194
CH60_HUMANHSPD1physical
28514442
SNX3_HUMANSNX3physical
28514442
FANCA_HUMANFANCAphysical
28215707

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SIR4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255; SER-261 ANDSER-262, AND MASS SPECTROMETRY.

TOP